MYCOF - Mydecine Innovations Group GAAP EPS of -C$0.13
2023-08-15 07:15:36 ET
More on Mydecine Innovations Group
- Mydecine modifies business model, says improved financial position
- Mydecine closes sale of Mindleap Health to PanGenomic
- Mydecine Innovations enters into $245K share subscription agreement, CFO resigns
- Mydecine submits pre-IND package to FDA for MYCO-001 in smoking cessation trial
For further details see:
Mydecine Innovations Group GAAP EPS of -C$0.13